Anna Batarina
Direktor/Vorstandsmitglied bei Baltiiskii Balkernyi Terminal
Profil
Ms. Anna Batarina, CFA, is a Partner at Apple Tree venture Managemnet Llc//vc, a Member at CFA Institute and a Vice President at Strategic Development Group, Inc. She is on the Board of Directors at Aulos Bioscience, Inc., Intergalactic Therapeutics, Inc., Marengo Therapeutics, Inc., Ascidian Therapeutics, Inc., Baltiiskii Balkernyi Terminal and Galvanize Therapeutics, Inc. Ms. Batarina was previously employed as a Vice President by Braeburn Pharmaceuticals, Inc. and a Head-Investor Relations & Capital Markets by Uralkali PJSC.
She received her undergraduate degree from Financial University, a graduate degree from The Johns Hopkins University, a graduate degree from Yale University and a graduate degree from Moscow State University Lomonosov.
Aktive Positionen von Anna Batarina
| Unternehmen | Position | Beginn |
|---|---|---|
| Baltiiskii Balkernyi Terminal | Direktor/Vorstandsmitglied | - |
CFA Institute
 CFA Institute Miscellaneous Commercial ServicesCommercial Services CFA Institute operates as non-profit organization, which engages in the provision of chartered financial analyst programs. It offers certificate in investment performance measurement program, investment foundations, and scholarship. The company was founded in 1965 and is headquartered in Charlottesville, VA. | Corporate Officer/Principal | - |
Ascidian Therapeutics, Inc.
 Ascidian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascidian Therapeutics, Inc. operates as a biotechnology research and development company. The company is headquartered in Brighton, MA. | Direktor/Vorstandsmitglied | - |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Private Equity Investor | 01.05.2019 |
Galvanize Therapeutics, Inc.
 Galvanize Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Galvanize Therapeutics, Inc. operates as a biotechnology firm. The company was founded in 2020 and is headquartered in Redwood City, CA. | Direktor/Vorstandsmitglied | - |
Strategic Development Group, Inc.
 Strategic Development Group, Inc. Miscellaneous Commercial ServicesCommercial Services Strategic Development Group, Inc. provides site selection and consulting services. It also offers headquarter site analysis and selection; incentive analysis and negotiation; and post location follow up. The company was founded by Mark Williams and is headquartered in Columbia, SC. | Private Equity Investor | - |
Aulos Bioscience, Inc.
 Aulos Bioscience, Inc. BiotechnologyHealth Technology Aulos Bioscience, Inc. operates as a biotechnology firm. The company is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
Intergalactic Therapeutics, Inc.
 Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Intergalactic Therapeutics, Inc. is a gene therapy company based in Baltimore, MD. The company is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal c3dna molecules. The company uses a customized approach to focal therapeutic delivery using its lead delivery technology, the comet pulsed electric field system, and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine. The company was founded by Michael D. Ehlers, and Theresa G. H. Heah has been the CEO of the company since 2023. | Direktor/Vorstandsmitglied | - |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Anna Batarina
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ | ░░░░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Ausbildung von Anna Batarina
| The Johns Hopkins University | Graduate Degree |
| Yale University | Graduate Degree |
| Moscow State University Lomonosov | Graduate Degree |
| Financial University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| URALKALI | Process Industries |
| Private Unternehmen | 10 |
|---|---|
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Finance |
CFA Institute
CFA Institute Miscellaneous Commercial ServicesCommercial Services CFA Institute operates as non-profit organization, which engages in the provision of chartered financial analyst programs. It offers certificate in investment performance measurement program, investment foundations, and scholarship. The company was founded in 1965 and is headquartered in Charlottesville, VA. | Commercial Services |
| Baltiiskii Balkernyi Terminal | |
Strategic Development Group, Inc.
Strategic Development Group, Inc. Miscellaneous Commercial ServicesCommercial Services Strategic Development Group, Inc. provides site selection and consulting services. It also offers headquarter site analysis and selection; incentive analysis and negotiation; and post location follow up. The company was founded by Mark Williams and is headquartered in Columbia, SC. | Commercial Services |
Braeburn, Inc.
 Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Braeburn, Inc. manufactures pharmaceutical products. It focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain and schizophrenia. The firm develops Probuphine for the treatment of adult patients with opioid dependence. The company was founded in 2012 and is headquartered in Princeton, NJ. | Commercial Services |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Health Technology |
Galvanize Therapeutics, Inc.
Galvanize Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Galvanize Therapeutics, Inc. operates as a biotechnology firm. The company was founded in 2020 and is headquartered in Redwood City, CA. | Commercial Services |
Ascidian Therapeutics, Inc.
Ascidian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascidian Therapeutics, Inc. operates as a biotechnology research and development company. The company is headquartered in Brighton, MA. | Health Technology |
Aulos Bioscience, Inc.
Aulos Bioscience, Inc. BiotechnologyHealth Technology Aulos Bioscience, Inc. operates as a biotechnology firm. The company is headquartered in Cambridge, MA. | Health Technology |
Intergalactic Therapeutics, Inc.
Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Intergalactic Therapeutics, Inc. is a gene therapy company based in Baltimore, MD. The company is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal c3dna molecules. The company uses a customized approach to focal therapeutic delivery using its lead delivery technology, the comet pulsed electric field system, and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine. The company was founded by Michael D. Ehlers, and Theresa G. H. Heah has been the CEO of the company since 2023. | Health Technology |
